Detalhe da pesquisa
1.
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer.
Breast Cancer Res
; 26(1): 3, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173005
2.
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
Br J Cancer
; 129(5): 811-818, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488446
3.
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.
Clin Cancer Res
; 28(6): 1107-1116, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980598
4.
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
Front Oncol
; 11: 827625, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223459
5.
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
Sci Rep
; 9(1): 20081, 2019 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31882586
6.
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.
Ther Adv Med Oncol
; 11: 1758835919833867, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31205497